Esempio: Heart Attack

Cerca studi clinici per: Eicosapentaenoic acid ethyl ester

Totale 87 risultati

NCT03885661

Attivo, non reclutamento

Vascepa to Accelerate Lipoprotein Uptake and Elimination

Condizioni: Lipid Disorder; Triglycerides High; Dyslipidemias
NCT04412018

Reclutamento

An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19

Condizioni: COVID-19; Inflammatory Response
NCT00839449

Completato

Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study

Condizioni: Subarachnoid Hemorrhage; Cerebral Vasospasm
NCT04562467

Reclutamento

The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk

Condizioni: Cardiovascular Diseases; Cardiovascular Risk Factor; Triglycerides High; Diabetes Mellitus, Type 2
NCT04505098

Reclutamento

A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults

Condizioni: Covid19; Atherosclerosis; Cardiovascular Diseases; Upper Respiratory Tract Infections
NCT04216251

Attivo, non reclutamento

PRevention Using EPA Against coloREctal Cancer

Condizioni: Colorectal Adenoma; Colorectal Cancer; Endoscopic Surgery; Eicosapentaenoic Acid; Gastrointestinal Microbiome
NCT02719327

Reclutamento

Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid

Condizioni: Alzheimer's Disease
NCT01492361

Completato

A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.

Condizioni: Cardiovascular Diseases
NCT04239950

Reclutamento

Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia

Condizioni: Hypertriglyceridemia
NCT02926027

Completato

Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy

Condizioni: Hypertriglyceridemia
NCT02422446

Terminato

Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects

Condizioni: Type 2 Diabetes; Coronary Artery Disease
NCT04460651

Reclutamento

PREPARE-IT. Prevention of COVID19 With EPA in Healthcare Providers at Risk - Intervention Trial

Condizioni: COVID19
NCT04177680

Attivo, non reclutamento

Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia

Condizioni: Hypertriglyceridemia
NCT04152291

Attivo, non reclutamento

The Effect of E-EPA on Circulating LDL and Plasma Lipid Metabolism

Condizioni: Atherosclerosis; Low-density Lipoproteins Aggregation Susceptibility; Low-density Lipoprotein Lipid Composition; Cardiovascular Diseases
NCT03428477

Reclutamento

EPA for Metastasis Trial 2

Condizioni: Liver Metastasis; Colon Cancer
NCT00231738

Completato

Protective Effect of EPA on Cardiovascular Events

Condizioni: Myocardial Infarction, Unstable Angina Pectoris, Sudden Cardiac Death, Stroke, Peripheral Artery Disease
NCT01047683

Completato

Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL

Condizioni: Hypertriglyceridemia
NCT01047501

Completato

Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)

Condizioni: Hypertriglyceridemia
NCT03693131

Completato

Efficacy of MND-2119 in Participants With Hypertriglyceridemia

Condizioni: Hypertriglyceridemia
NCT02940223

Terminato

Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer

Condizioni: Advanced Malignant Neoplasm; Fatigue
NCT02859129

Completato

Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®)

Condizioni: Hypertriglyceridemia
NCT03661047

Reclutamento

OMega-3 Fatty Acid for the Immune Modulation of Colorectal Cancer

Condizioni: Colon Cancer
NCT04682665

Non ancora reclutando

Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases

Condizioni: Colon Cancer Liver Metastasis
NCT02113163

Stato sconosciuto

PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA

Condizioni: Diabetes Mellitus, Non-Insulin-Dependent; Hypertriglyceridemia
NCT00692718

Stato sconosciuto

N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure

Condizioni: Acute Heart Failure; Acute Myocardial Infarction